Evaluation of newer drugs (Linezolid & Meropenem) and classical second line drugs (Amikacin & Levofloxacin) in clinical isolates of MDR-TB utilizing broth based Bactec MGIT 960 technique
JavaScript is disabled for your browser. Some features of this site may not work without it.
Evaluation of newer drugs (Linezolid & Meropenem) and classical second line drugs (Amikacin & Levofloxacin) in clinical isolates of MDR-TB utilizing broth based Bactec MGIT 960 technique